Abstract
Objectives-To further evaluate the role of bacterial antigens in triggering inflammation in the joint in patients with reactive arthritis by studying local antibody synthesis in the joint. Methods-Yersinia-specific antibodies in paired serum and synovial fluid samples from 29 patients with yersinia triggered reactive arthritis were studied using an enzyme linked immunosorbent assay (ELISA), an inhibition ELISA with six monoclonal antibodies against lipo Certain infections of the gastrointestinal and urogenital tract, such as those caused by yersiniae and salmonellae, are sometimes followed by development of reactive arthritis (ReA), especially in patients carrying HLA-B27. In the development of ReA host-microbe interaction is important, but the exact pathogenic mechanisms of arthritis are largely unknown.' 2 Despite negative attempts to culture bacteria from synovial fluids, there is strong direct evidence for the presence of microbial components, especially lipopolysaccharide (LPS), in the affected joints in patients with ReA.'-5 In addition, the concentration of total polymeric IgA has been shown to be higher in synovial fluid than in serum in patients with Reiter's disease and ReA to indicate local antibody production.6 Further, in two studies with small groups of patients with salmonella and Chlamydia trachomnatis triggered ReA, evidence for intra-articular production of specific antibodies was obtained.7 However, mechanisms leading to inflammation in synovium and the possible role for microbial antigens and antibodies in propagating these events is not understood.
In the present work, to further evaluate the role of bacterial antigens in triggering inflammation in the joint, we studied local antibody synthesis by measuring yersiniaspecific antibody levels in paired samples of serum and synovial fluid from patients with yersinia triggered ReA using an enzyme linked immunosorbent assay (ELISA). Antibodies of IgM, IgG and IgA classes, as well as antibodies of IgA subclasses and those containing secretory component (sIgA) were measured against LPS and/or sodium dodecyl sulphate (SDS) extract of whole Yersinia enterocolitica 0:3 bacteria. Antibody levels were also measured by inhibition-ELISA against two of the plasmid encoded released proteins (RPs), which are proteins released into calcium deficient media by human enteropathogenetic strains of yersinia.9 The pattern of antigen specificity was further evaluated by inhibition-ELISA with four monoclonal antibodies (MoAbs) directed against different parts of LPS, as well as by immunoblotting.
Patients and methods

PATIENTS AND SAMPLES
Paired serum and synovial fluid samples from 29 patients infected with Y enterocolitica 0:3 were chosen from our large panel of samples collected from reactive arthritis patients for the present studies. Diagnosis of Yersinia infection was based in all patients on the typical clinical picture (diarrhoea, abdominal pain, vomiting and/or arthritis) and clearly increased levels of anti-yersinia antibodies detected by ELISA,'0 in 16 cases, additionally, the pathogen was isolated from the stools. Age of the patients ranged from 13 to 72 years (mean 35), and the female to male ratio was 9:20. All patients developed ReA as a post infectious complication within three weeks after the onset of National Public Health Institute, Department in Turku, Finland 0 Maki-Ikola* infection. Of the 27 patients tested, 23 were positive for the HLA B27 antigen. Serum and synovial fluid samples were collected simultaneously at 13 days to two months after the onset of infection; from one patient samples were taken at 8&5 months after the onset of infection. Synovial fluid aspirated from the knee was mixed with heparin (50 IU/ml), centrifugated at 200 g for 10 minutes and the supernatant was used for analysis. Both synovial fluid and serum samples were stored at -20C and studied simultaneously.
Serum and synovial fluid samples from nine patients with ReA triggered by microbes other than yersiniae (5, salmonellae; 2, Chlamydia trachomatis; 1, Y pseudotuberculosis and 1, unknown aetiology), from four patients with rheumatoid arthritis and from nine patients with swollen joints for other reasons (6 with swollen knee with unknown reason; 4 with chronic synovial inflammation with unknown reason, and 1 with colitis ulcerosa) served as controls.
ANTIGENS
As the source of RPs, plasmid-positive strain of Y enterocolitica 0:3 was grown and RPs prepared as previously described.9 11 The LPS was extracted from Y enterocolitica 0:3 using the phenol-water method. ' After washings, 60 pl of goat alkaline phosphatase-conjugated antiserum (absorbed with human serum) specific for mouse IgG and IgM (TAGO, Burlingame, California) was added at a dilution of 1:4000 and incubated at 3 hours at 37°C. Quantitation by enzyme substrate was carried out as described earlier.
Results were compared with values obtained by the MoAb alone (without serum sample) to calculate the inhibition percentage as described earlier. 10 Yersinia-specific antibodies in serum and synovial fluid in patients with versinia triggered reactive arthritis (table 1) . In all assays the correlation between the antibody concentrations in serum and synovial fluid was good: Spearman's correlation coefficient was from 0 59 to 090 (p from 00022 to 0 0001). The antibody levels against the SDS extract of whole bacteria as well as the LPS were significantly higher in the sera compared with the synovial fluid samples in IgM, IgG and IgA classes, as well as in sIgA (p from < 0 04 to 0 0001); especially clearly the difference was seen in the IgM and sIgA classes. In the IgAl and IgA2 subclass analysis there were no differences in the antibody levels between the sera and synovial fluid samples. No significant differences were found between the absorbance values in the SDS extract ELISA and the LPS ELISA indicating that the majority of the antibodies are directed against the LPS part of the bacteria. INHIBITION Similarly, when paired serum and synovial fluid samples were studied, there were no significant differences in the antibody concentrations against the MoAb 2B5-, A6-, 6B6-and 2C1-defined epitopes of Y enterocolitica 0:3 LPS between sera and synovial fluids (table 2). There was a good correlation between the antibody concentrations in sera and synovial fluids in all assays; Spearman's correlation coefficient was from 0 70 to 0-96 (p from 0-0002 to 0-0000).
IMMUNOBLOTr-TING
To study whether we can identify qualitative differences in the antibody reactivity to various yersinia antigens, paired serum and synovial fluid samples were analysed by immunblotting with whole Y enterocolitica 0:3 bacteria as antigen in the nitrocellulose sheet. Based on this extensive analysis, identical panel of Y enterocolitica antigens was recognised by IgG and IgA of the serum and synovial fluid samples (figure).
CONTROL ELISAS
The antibody level in serum samples was higher than in synovial fluid samples when IgG class antibodies against tetanus toxoid, measles and rubella were studied. Also the level of IgM, IgG and IgA class antibodies against Candida albicans was higher in serum samples compared with synovial fluid samples ( tAntibody concentrations between serum and synovial fluid samples are compared Discussion In the present study we demonstrate that in patients with yersinia triggered ReA yersiniaspecific antibodies in the synovial fluid mirror those in the serum as judged by concentration, by specificity or by distribution in antibody classes or subclasses (p always <0 003 for correlation). When there was a statistically significant difference in the antibody concentrations between serum and synovial fluid samples, the antibody level was always higher in serum compared to synovial fluid. These results do not speak for any strong local antibody production, but indicate that the majority of yersinia antibodies in the synovial fluid are derived from the circulation. The results from assays with microbes unrelated to yersinia infections as antigens support this concept. Accordingly, no significant differences were found in the antibody levels against Chlamydia trachomatis, Yersinia enterocolitica or Borrelia burgdorferi between serum and synovial fluid samples from patients with undifferentiated oligoarthritis.'9 Further, the difference in antibody concentrations between serum and synovial fluid samples was biggest in IgM and sIgA (the largest immunoglobulin molecules in size) assays, which is in line with the above suggestion of filtration of the antibodies from circulation into the joint.
Controversially, we have recently found evidence for intra-articular antibody production of IgA2 subclass against salmonella LPS in patients with salmonella triggered ReA. Yersinia-specific antibodies in serumn and synovial fluid in patients with versinia triggered reactive arthritis Likewise, it is possible that the finding of similar levels in serum and synovial fluid yersinia-specific IgAl and IgA2 subclasses, as well as of IgA and IgG classes would be of some importance, since the differences between antibody levels in serum and synovial fluid in other immunoglobulin classes and in controls against other organisms are much more striking than in these mentioned tests.
The role of RPs in the pathogenesis of ReA has not been well studied yet. There are some indications for RPs to play some role in the pathogenesis of ReA: 1) patients with yersinia triggered ReA have more often antibodies against the 36 kD RP and higher concentrations of antibodies against the 26 kD RP in the beginning of the disease than the patients who recover from the infection without arthritis;" '4 2) total amount of IgA class antibodies against RPs is significantly higher in arthritic patients in the beginning of the disease;'5 3) yersinia bacilli was demonstrated in the intestinal biopsy specimens of patients with yersinia-triggered ReA by immunofluorescence using monospecific rabbit antiserum to 46 kD RP24 and 4) strong T-cell reactivity to RPs was detected in synovial fluid samples taken from patients with reactive arthritis. 25 26 In the present study we could find no evidence for intra-articular antibody production against the two MoAb-defined epitopes of 26 kD and 46 kD RPs. The intrasynovial antibodies also against RPs may have therefore filtrated to the joint from the circulation rather than been produced locally. Thus the involvement of RPs in the pathogenesis of ReA remains open to speculation.
In ReA, microbial antigens enter the body via mucosal surfaces. Subsequently, microbial LPS is transported to the joints. -5 Microbial antibodies are produced and may filtrate into the synovium from circulation, or as in case of salmonella triggered ReA, they may be produced locally in the joints.8 Antibodies may also be transported to the joint as part of immune complexes, as immune complexes consisting of yersinia antigen and specific antibody are found in the circulation as well as in synovial fluid in yersinia triggered ReA. 27 The specific antibodies together with microbial antigens in the joint may participate in inflammation and tissue injury through complement activation. LPS may play an important role in these events, as a major part of yersinia-specific antibodies in serum and synovial fluid in patients with ReA were directed against LPS. Our previous studies also suggest a crucial role for LPS in the pathogenesis of ReA. 1-4 8 10 
